Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LANADELUMAB
- A Study of Lanadelumab (SHP643) in Chinese Participants With Hereditary Angioedema (HAE)
- A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE)
- Hemodialysis.-Induced Hypotension Therapy for End Stage Kidney Disease
- Inhibition of Plasma Kallikrein as a New Therapy for Lung Injury
- Expanded Access Program With Lanadelumab for Japanese People With Hereditary Angioedema
- Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients
- A Study to Determine the Safety, Tolerability, and Pharmacokinetics of Lanadelumab Administered Intravenously in Healthy Adult Volunteer Participants
- Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia
- A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor
- Lanadelumab in FXII-associated Cold Autoinflammatory Syndrome (FACAS)
- A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)
- Efficacy and Safety of Lanadelumab (SHP643) in Japanese Participants With Hereditary Angioedema (HAE)
- A Study of Lanadelumab to Prevent Hereditary Angioedema (HAE) Attacks in Children
- A Study to Determine the Bioavailability of Lanadelumab (SHP643) Administered Subcutaneously With the Prefilled Syringe and the Autoinjector in Healthy Adult Volunteer Participants.
- Study of Lanadelumab in Healthy Japanese and Matched Caucasian Adult Subjects
Clinical trials list
click for details